Click here to get full coverage on Rhythm Pharmaceuticals stock jumps as Goldman Sachs raises price target on PWS study - Investing.com

Rhythm Pharmaceuticals stock jumps as Goldman Sachs raises price target on PWS study  Investing.com

Rhythm Pharmaceuticals stock jumps as Goldman Sachs raises price target on PWS study - Investing.com

Click here to get full coverage on Eye-tracking test adapted to better measure hunger behaviors in PWS - Prader-Willi Syndrome News

Eye-tracking test adapted to better measure hunger behaviors in PWS  Prader-Willi Syndrome News

Eye-tracking test adapted to better measure hunger behaviors in PWS - Prader-Willi Syndrome News

Click here to get full coverage on PWS plays key role at Latin Grammy Awards - LSi Online

PWS plays key role at Latin Grammy Awards  LSi Online

PWS plays key role at Latin Grammy Awards - LSi Online

Click here to get full coverage on Rhythm: PWS Signal, HO Speed Bump, And The Case For A Rare-Obesity Blockbuster (RYTM) - Seeking Alpha

Rhythm: PWS Signal, HO Speed Bump, And The Case For A Rare-Obesity Blockbuster (RYTM)  Seeking Alpha

Rhythm: PWS Signal, HO Speed Bump, And The Case For A Rare-Obesity Blockbuster (RYTM) - Seeking Alpha

Click here to get full coverage on Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga

Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise  Benzinga

Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga

Click here to get full coverage on RYTM: Setmelanotide showed promising BMI and hyperphagia improvements in PWS, supporting phase 3 plans - TradingView

RYTM: Setmelanotide showed promising BMI and hyperphagia improvements in PWS, supporting phase 3 plans  TradingView

RYTM: Setmelanotide showed promising BMI and hyperphagia improvements in PWS, supporting phase 3 plans - TradingView

Click here to get full coverage on Rhythm teases weight-loss results for Imcivree in Prader-Willi - FirstWord Pharma

Rhythm teases weight-loss results for Imcivree in Prader-Willi  FirstWord Pharma

Rhythm teases weight-loss results for Imcivree in Prader-Willi - FirstWord Pharma

Click here to get full coverage on Rhythm Pharmaceuticals (Nasdaq: RYTM) sees BMI, hunger drops in PWS Phase 2 trial - Stock Titan

Rhythm Pharmaceuticals (Nasdaq: RYTM) sees BMI, hunger drops in PWS Phase 2 trial  Stock Titan

Rhythm Pharmaceuticals (Nasdaq: RYTM) sees BMI, hunger drops in PWS Phase 2 trial - Stock Titan

Click here to get full coverage on Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial - TipRanks

Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial  TipRanks

Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial - TipRanks

Click here to get full coverage on Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome - GlobeNewswire

Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome  GlobeNewswire

Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome - GlobeNewswire

Click here to get full coverage on Sparc Hydrogen moves to operational testing at pilot Aussie PWS project - Renewables Now

Sparc Hydrogen moves to operational testing at pilot Aussie PWS project  Renewables Now

Sparc Hydrogen moves to operational testing at pilot Aussie PWS project - Renewables Now

Click here to get full coverage on Rhythm Pharmaceuticals Announces Preliminary Phase 2 Trial Results for Setmelanotide in PWS - TradingView

Rhythm Pharmaceuticals Announces Preliminary Phase 2 Trial Results for Setmelanotide in PWS  TradingView

Rhythm Pharmaceuticals Announces Preliminary Phase 2 Trial Results for Setmelanotide in PWS - TradingView

Click here to get full coverage on Rhythm Pharmaceuticals stock holds Buy rating at TD Cowen on PWS trial data - Investing.com

Rhythm Pharmaceuticals stock holds Buy rating at TD Cowen on PWS trial data  Investing.com

Rhythm Pharmaceuticals stock holds Buy rating at TD Cowen on PWS trial data - Investing.com

Click here to get full coverage on Diabetes medications may support kidney health in adults with PWS - Prader-Willi Syndrome News

Diabetes medications may support kidney health in adults with PWS  Prader-Willi Syndrome News

Diabetes medications may support kidney health in adults with PWS - Prader-Willi Syndrome News

Click here to get full coverage on Rhythm Pharmaceuticals to release PWS trial data on Thursday - Investing.com

Rhythm Pharmaceuticals to release PWS trial data on Thursday  Investing.com

Rhythm Pharmaceuticals to release PWS trial data on Thursday - Investing.com

Click here to get full coverage on Siblings of PWS patients require tailored support as they grow up - Prader-Willi Syndrome News

Siblings of PWS patients require tailored support as they grow up  Prader-Willi Syndrome News

Siblings of PWS patients require tailored support as they grow up - Prader-Willi Syndrome News

Click here to get full coverage on First trial data on setmelanotide for PWS obesity expected this year - Prader-Willi Syndrome News

First trial data on setmelanotide for PWS obesity expected this year  Prader-Willi Syndrome News

First trial data on setmelanotide for PWS obesity expected this year - Prader-Willi Syndrome News

Click here to get full coverage on Riding the emotional roller coaster of caring for my son with PWS - Prader-Willi Syndrome News

Riding the emotional roller coaster of caring for my son with PWS  Prader-Willi Syndrome News

Riding the emotional roller coaster of caring for my son with PWS - Prader-Willi Syndrome News

Click here to get full coverage on Aardvark doses first Australian patient in phase 3 PWS hunger trial - Investing.com Nigeria

Aardvark doses first Australian patient in phase 3 PWS hunger trial  Investing.com Nigeria

Aardvark doses first Australian patient in phase 3 PWS hunger trial - Investing.com Nigeria

Click here to get full coverage on PWS can lead to lower life expectancy, caregiver strain, high costs - Prader-Willi Syndrome News

PWS can lead to lower life expectancy, caregiver strain, high costs  Prader-Willi Syndrome News

PWS can lead to lower life expectancy, caregiver strain, high costs - Prader-Willi Syndrome News

Click here to get full coverage on Rhythm Pharma rises on positive mid-stage data for rare disease therapy - TradingView

Rhythm Pharma rises on positive mid-stage data for rare disease therapy  TradingView

Rhythm Pharma rises on positive mid-stage data for rare disease therapy - TradingView

Click here to get full coverage on My son’s first PWS camping trip was a success - Prader-Willi Syndrome News

My son’s first PWS camping trip was a success  Prader-Willi Syndrome News

My son’s first PWS camping trip was a success - Prader-Willi Syndrome News

Click here to get full coverage on Clinical trial being planned to test nasal spray using oxytocin for PWS - Prader-Willi Syndrome News

Clinical trial being planned to test nasal spray using oxytocin for PWS  Prader-Willi Syndrome News

Clinical trial being planned to test nasal spray using oxytocin for PWS - Prader-Willi Syndrome News

Click here to get full coverage on Prader-Willi Syndrome (PWS) Market was valued at USD 350-400 - openPR.com

Prader-Willi Syndrome (PWS) Market was valued at USD 350-400  openPR.com

Prader-Willi Syndrome (PWS) Market was valued at USD 350-400 - openPR.com

Click here to get full coverage on Relmada taking steps to launch clinical trial of sepranolone in PWS - Prader-Willi Syndrome News

Relmada taking steps to launch clinical trial of sepranolone in PWS  Prader-Willi Syndrome News

Relmada taking steps to launch clinical trial of sepranolone in PWS - Prader-Willi Syndrome News

Click here to get full coverage on Top-line Phase 3 trial data on ACP-101 for PWS expected this year - Prader-Willi Syndrome News

Top-line Phase 3 trial data on ACP-101 for PWS expected this year  Prader-Willi Syndrome News

Top-line Phase 3 trial data on ACP-101 for PWS expected this year - Prader-Willi Syndrome News

Click here to get full coverage on Prader–Willi syndrome corrected in human hypothalamic organoids - Nature

Prader–Willi syndrome corrected in human hypothalamic organoids  Nature

Prader–Willi syndrome corrected in human hypothalamic organoids - Nature

Click here to get full coverage on Professional Wireless Systems (PWS) Manages Over 1,000 Wireless Frequencies For Dreamforce 2025 - Live Design Online

Professional Wireless Systems (PWS) Manages Over 1,000 Wireless Frequencies For Dreamforce 2025  Live Design Online

Professional Wireless Systems (PWS) Manages Over 1,000 Wireless Frequencies For Dreamforce 2025 - Live Design Online

Click here to get full coverage on PWS-related hyperphagia drug ACP-101 fails to meet trial goals - Prader-Willi Syndrome News

PWS-related hyperphagia drug ACP-101 fails to meet trial goals  Prader-Willi Syndrome News

PWS-related hyperphagia drug ACP-101 fails to meet trial goals - Prader-Willi Syndrome News

Click here to get full coverage on Helping children with PWS navigate their school systems - Prader-Willi Syndrome News

Helping children with PWS navigate their school systems  Prader-Willi Syndrome News

Helping children with PWS navigate their school systems - Prader-Willi Syndrome News

Click here to get full coverage on Potential PWS therapeutic target discovered, study suggests - Prader-Willi Syndrome News

Potential PWS therapeutic target discovered, study suggests  Prader-Willi Syndrome News

Potential PWS therapeutic target discovered, study suggests - Prader-Willi Syndrome News

Click here to get full coverage on Can BMB-105 ease insatiable hunger in PWS? Program to find out. - Prader-Willi Syndrome News

Can BMB-105 ease insatiable hunger in PWS? Program to find out.  Prader-Willi Syndrome News

Can BMB-105 ease insatiable hunger in PWS? Program to find out. - Prader-Willi Syndrome News

Click here to get full coverage on ARD-101 Phase 3 trial expands to PWS patients as young as 10 - Prader-Willi Syndrome News

ARD-101 Phase 3 trial expands to PWS patients as young as 10  Prader-Willi Syndrome News

ARD-101 Phase 3 trial expands to PWS patients as young as 10 - Prader-Willi Syndrome News

Click here to get full coverage on Soleno pledges $5M in research funding to look for PWS cure - Prader-Willi Syndrome News

Soleno pledges $5M in research funding to look for PWS cure  Prader-Willi Syndrome News

Soleno pledges $5M in research funding to look for PWS cure - Prader-Willi Syndrome News

Click here to get full coverage on Trial testing ARD-101 for hunger in PWS to also enroll younger children - Prader-Willi Syndrome News

Trial testing ARD-101 for hunger in PWS to also enroll younger children  Prader-Willi Syndrome News

Trial testing ARD-101 for hunger in PWS to also enroll younger children - Prader-Willi Syndrome News

Click here to get full coverage on Growth hormone for PWS may increase diabetes risk, study finds - Prader-Willi Syndrome News

Growth hormone for PWS may increase diabetes risk, study finds  Prader-Willi Syndrome News

Growth hormone for PWS may increase diabetes risk, study finds - Prader-Willi Syndrome News

Click here to get full coverage on Genetic deletion may drive obesity in PWS adults: Study - Prader-Willi Syndrome News

Genetic deletion may drive obesity in PWS adults: Study  Prader-Willi Syndrome News

Genetic deletion may drive obesity in PWS adults: Study - Prader-Willi Syndrome News

Click here to get full coverage on First Drug Approved for Hyperphagia in Prader-Willi Syndrome - Inside Precision Medicine

First Drug Approved for Hyperphagia in Prader-Willi Syndrome  Inside Precision Medicine

First Drug Approved for Hyperphagia in Prader-Willi Syndrome - Inside Precision Medicine

Click here to get full coverage on Hormone therapy side effects challenge girls with PWS - Prader-Willi Syndrome News

Hormone therapy side effects challenge girls with PWS  Prader-Willi Syndrome News

Hormone therapy side effects challenge girls with PWS - Prader-Willi Syndrome News

Click here to get full coverage on Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint - Business Wire

Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint  Business Wire

Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint - Business Wire

Click here to get full coverage on Anxiety common in children with PWS, caregiver survey says - Prader-Willi Syndrome News

Anxiety common in children with PWS, caregiver survey says  Prader-Willi Syndrome News

Anxiety common in children with PWS, caregiver survey says - Prader-Willi Syndrome News

Click here to get full coverage on Acadia pulls plug on Prader-Willi drug after trial flop - FirstWord Pharma

Acadia pulls plug on Prader-Willi drug after trial flop  FirstWord Pharma

Acadia pulls plug on Prader-Willi drug after trial flop - FirstWord Pharma

Click here to get full coverage on DCCR now under review in EU as hyperphagia treatment in PWS - Prader-Willi Syndrome News

DCCR now under review in EU as hyperphagia treatment in PWS  Prader-Willi Syndrome News

DCCR now under review in EU as hyperphagia treatment in PWS - Prader-Willi Syndrome News

Click here to get full coverage on Vykat XR restart reduces insatiable hunger in PWS patients: Trial data - Prader-Willi Syndrome News

Vykat XR restart reduces insatiable hunger in PWS patients: Trial data  Prader-Willi Syndrome News

Vykat XR restart reduces insatiable hunger in PWS patients: Trial data - Prader-Willi Syndrome News

Click here to get full coverage on How our son’s Prader-Willi meltdowns affected family life - Prader-Willi Syndrome News

How our son’s Prader-Willi meltdowns affected family life  Prader-Willi Syndrome News

How our son’s Prader-Willi meltdowns affected family life - Prader-Willi Syndrome News

Click here to get full coverage on Imbalance of fat molecules predicts risk in children with PWS: Study - Prader-Willi Syndrome News

Imbalance of fat molecules predicts risk in children with PWS: Study  Prader-Willi Syndrome News

Imbalance of fat molecules predicts risk in children with PWS: Study - Prader-Willi Syndrome News

Click here to get full coverage on Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH - Yahoo Finance

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH  Yahoo Finance

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH - Yahoo Finance

Click here to get full coverage on PWS salmon harvest tops 37M fish, prices begin decline - The Cordova Times

PWS salmon harvest tops 37M fish, prices begin decline  The Cordova Times

PWS salmon harvest tops 37M fish, prices begin decline - The Cordova Times

Click here to get full coverage on Hyperphagia treatment Vykat XR for PWS now available in US - Prader-Willi Syndrome News

Hyperphagia treatment Vykat XR for PWS now available in US  Prader-Willi Syndrome News

Hyperphagia treatment Vykat XR for PWS now available in US - Prader-Willi Syndrome News

Click here to get full coverage on Aardvark doses first Australian patient in phase 3 PWS hunger trial - Investing.com Canada

Aardvark doses first Australian patient in phase 3 PWS hunger trial  Investing.com Canada

Aardvark doses first Australian patient in phase 3 PWS hunger trial - Investing.com Canada

Click here to get full coverage on Acadia Scraps Prader-Willi Drug After Late-Stage Failure - BioSpace

Acadia Scraps Prader-Willi Drug After Late-Stage Failure  BioSpace

Acadia Scraps Prader-Willi Drug After Late-Stage Failure - BioSpace

Click here to get full coverage on FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome - NeurologyLive

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome  NeurologyLive

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome - NeurologyLive

Click here to get full coverage on Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS) - Yahoo Finance

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)  Yahoo Finance

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS) - Yahoo Finance

Click here to get full coverage on Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno - Fierce Pharma

Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno  Fierce Pharma

Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno - Fierce Pharma

Click here to get full coverage on Worldwide PWS community to make way for awareness month - Prader-Willi Syndrome News

Worldwide PWS community to make way for awareness month  Prader-Willi Syndrome News

Worldwide PWS community to make way for awareness month - Prader-Willi Syndrome News

Click here to get full coverage on PWS Honored Graduate: Madeline Martin's Interdisciplinary Approach to Science - BYU Life Sciences

PWS Honored Graduate: Madeline Martin's Interdisciplinary Approach to Science  BYU Life Sciences

PWS Honored Graduate: Madeline Martin's Interdisciplinary Approach to Science - BYU Life Sciences

Click here to get full coverage on Phase 2 trial testing setmelanotide for PWS set to start soon... - Prader-Willi Syndrome News

Phase 2 trial testing setmelanotide for PWS set to start soon...  Prader-Willi Syndrome News

Phase 2 trial testing setmelanotide for PWS set to start soon... - Prader-Willi Syndrome News

Click here to get full coverage on FDA approves DCCR, now Vykat XR, to ease hyperphagia in PWS - Prader-Willi Syndrome News

FDA approves DCCR, now Vykat XR, to ease hyperphagia in PWS  Prader-Willi Syndrome News

FDA approves DCCR, now Vykat XR, to ease hyperphagia in PWS - Prader-Willi Syndrome News

Click here to get full coverage on ARD-101 for Prader-Willi syndrome - Prader-Willi Syndrome News

ARD-101 for Prader-Willi syndrome  Prader-Willi Syndrome News

ARD-101 for Prader-Willi syndrome - Prader-Willi Syndrome News

Click here to get full coverage on Masque, PWS Stock Up on Spectera - Mixonline

Masque, PWS Stock Up on Spectera  Mixonline

Masque, PWS Stock Up on Spectera - Mixonline

Click here to get full coverage on Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome - Nature

Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome  Nature

Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome - Nature

Click here to get full coverage on Rescue of imprinted genes by epigenome editing in human cellular models of Prader-Willi syndrome - Nature

Rescue of imprinted genes by epigenome editing in human cellular models of Prader-Willi syndrome  Nature

Rescue of imprinted genes by epigenome editing in human cellular models of Prader-Willi syndrome - Nature

Click here to get full coverage on Can CRISPR Offer a Cure for Prader-Willi Syndrome? - Technology Networks

Can CRISPR Offer a Cure for Prader-Willi Syndrome?  Technology Networks

Can CRISPR Offer a Cure for Prader-Willi Syndrome? - Technology Networks

Click here to get full coverage on Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold (NASDAQ:ACAD) - Seeking Alpha

Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold (NASDAQ:ACAD)  Seeking Alpha

Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold (NASDAQ:ACAD) - Seeking Alpha

Click here to get full coverage on Gene-editing tool successfully reactivates genes in PWS lab study - Prader-Willi Syndrome News

Gene-editing tool successfully reactivates genes in PWS lab study  Prader-Willi Syndrome News

Gene-editing tool successfully reactivates genes in PWS lab study - Prader-Willi Syndrome News

Click here to get full coverage on Bright Minds adds four PWS experts to scientific advisory board - Investing.com

Bright Minds adds four PWS experts to scientific advisory board  Investing.com

Bright Minds adds four PWS experts to scientific advisory board - Investing.com

Click here to get full coverage on Review of PARKSIDE PWS 125 I9 Angle Grinder: Detailed Look at Its Features and Performance - Root-Nation.com

Review of PARKSIDE PWS 125 I9 Angle Grinder: Detailed Look at Its Features and Performance  Root-Nation.com

PWS

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About PWS

Latest News

Rhythm Pharmaceuticals stock jumps as Goldman Sachs raises price target on PWS study - Investing.com

Eye-tracking test adapted to better measure hunger behaviors in PWS - Prader-Willi Syndrome News

PWS plays key role at Latin Grammy Awards - LSi Online

Advanced Charts

Fund Information